Lebovitz, 1983 - Google Patents
Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitusLebovitz, 1983
- Document ID
- 14089579317625188896
- Author
- Lebovitz H
- Publication year
- Publication venue
- The American Journal of Medicine
External Links
Snippet
Clinical usage of the sulfonylurea drugs is based on experience in well-controlled long-term studies in large numbers of patients. The results of such studies indicate that approximately 60 to 70 percent of the patients with noninsulin-dependent diabetes mellitus of recent onset …
- 208000001072 Type 2 Diabetes Mellitus 0 title abstract description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/866—Diabetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lauritzen et al. | Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy | |
Mühlhauser et al. | Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes: the Bucharest-Düsseldorf study | |
Leslie et al. | Diabetic retinopathy in identical twins | |
Boudoulas et al. | Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine--cardiovascular process. | |
Sönksen et al. | Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus | |
Hother-Nielsen et al. | Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes | |
Hosker et al. | Similar reduction of first-and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy | |
Baker et al. | A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients | |
BODEN et al. | Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin | |
Pomeranze et al. | Clinical report of a new hypoglycemic agent | |
Lebovitz | Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus | |
Cutting et al. | Relationship between blood cholesterol and increased metabolism from dinitrophenol and thyroid | |
Schnack et al. | Effects of 8-wk α-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients | |
Howe-Davies et al. | Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight | |
Longnecker et al. | Insulin and a Sulfonylurea Agent in Non–Insulin-Dependent Diabetes Mellitus | |
Groop et al. | Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM | |
Kreitzman et al. | Safety and effectiveness of weight reduction using a very-low-calorie formulated food | |
Hocken et al. | Reduction of free water clearance by chlorporpamide. | |
Adam et al. | Model for the investigation of intractable hypoglycemia: Insulin-glucose interrelationships during steady state infusions | |
Ohneda et al. | Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus | |
Cole et al. | Blood glucose monitoring in symptomatic hypoglycemia | |
Galun et al. | Insulinoma complicating pregnancy: case report and review of the literature | |
Adadevoh et al. | Serum levels of doxycycline in normal subjects after a single oral dose. | |
Bhatia et al. | Glibenclamide therapy in diabetes mellitus | |
Meacham et al. | Preservation of somatostatin secretion in cystic fibrosis patients with diabetes. |